Categories: Entertainment

NYSE Content Advisory: Pre-Market update + Tax Firm Andersen Raises $176 Million in NYSE IPO

NEW YORK, Dec. 17, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

- Advertisement -

Kristen Scholer delivers the pre-market update on December 17th

- Advertisement -
  • U.S. equities are modestly higher as Wall Street digests delayed economic reports from the government shutdown. Non-farm payrolls showed a cooling labor market, but not enough to spark expectations of a rate cut before the Fed’s Jan. 28 decision.
  • Tax advisory firm Andersen rings the opening bell after raising $176M at $16/share (NYSE: ANDG). Watch NYSE Live at 9 a.m. ET on the NYSE TV app for CEO Mark Vorsatz’s remarks and an exclusive trading floor interview.
  • The TOV ETF team rings the closing bell ahead of a Menorah lighting ceremony. TOV invests through a “Jewish lens” and has ties to the ADL. Catch Taking Stock at 4 p.m. ET on LinkedIn featuring ADL CEO Jonathan Greenblatt.

Opening Bell
Andersen Group (NYSE: ANDG) celebrates its IPO

- Advertisement -

Closing Bell
The ADL and JLens Network celebrate the first Jewish advocacy ETF, TOV

- Advertisement -

Click here to download the NYSE TV App

- Advertisement -

 

- Advertisement -

Video – https://mma.prnewswire.com/media/2847761/NYSE_Market_Update_Dec_17.mp4 
Logo – https://mma.prnewswire.com/media/2581322/New_York_Stock_Exchange_Logo.jpg 

- Advertisement -

 

- Advertisement -

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/nyse-content-advisory-pre-market-update–tax-firm-andersen-raises-176-million-in-nyse-ipo-302644753.html

- Advertisement -
PRNW Agency

Recent Posts

ITM Announces Phase 3 COMPETE Patient-Reported Quality of Life Data with n.c.a. Lu-edotreotide (ITM-11) vs. Everolimus at ASCO 2026

Exploratory analysis showed favorable patient-reported quality of life outcomes and delayed time to deterioration in…

4 hours ago

ImPact Biotech Presents Updated Data from Phase 1 Trial of Padeliporfin VTP in LA-PDAC and Phase 3 ENLIGHTED Trial in LG-UTUC at ASCO 2026

– Updated data across two dose levels of 200 mW/cm and 400 mW/cm in LA-PDAC…

4 hours ago

Fobi AI Provides Corporate Update Regarding FFCTO Revocation Process and Q3 Interim Filings

May 29, 2026 21:18 ET  | Source: Fobi AI Inc. VANCOUVER, BC, May 29, 2026…

11 hours ago

Crypto News Today: AlphaPepe Presale Stage 17 Nears Sell Out While XRP Price Prediction Eyes $7.00

MONACO, May 29, 2026 (GLOBE NEWSWIRE) -- Crypto news today is turning toward AlphaPepe as…

11 hours ago